Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03184870
Title A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
Local Institution - 0003 Birmingham Alabama 35233 United States Details
Local Institution - 0026 Phoenix Arizona 85054 United States Details
Local Institution - 0002 Los Angeles California 90033 United States Details
Local Institution - 0025 Los Angeles California 90033 United States Details
Local Institution - 0041 Orange California 92868-3201 United States Details
Local Institution - 0015 Aurora Colorado 80045 United States Details
Local Institution - 0018 Washington District of Columbia 20007 United States Details
Local Institution - 0048 Brooksville Florida 34613 United States Details
Local Institution - 0047 Saint Petersburg Florida 33705 United States Details
Local Institution - 0005 Baltimore Maryland 21287 United States Details
Local Institution - 0033 Boston Massachusetts 02114 United States Details
Local Institution - 0027 Rochester Minnesota 55905-0001 United States Details
Local Institution - 0039 Hattiesburg Mississippi 39401 United States Details
Local Institution - 0023 Saint Louis Missouri 63110 United States Details
Local Institution - 0004 Hackensack New Jersey 07601 United States Details
Local Institution - 0017 New York New York 10065 United States Details
Local Institution - 0024 Rochester New York 14642 United States Details
Local Institution - 0046 Charlotte North Carolina 28204 United States Details
Local Institution - 0044 Cleveland Ohio 44106-5055 United States Details
Local Institution - 0021 Cleveland Ohio 44195 United States Details
Local Institution - 0037 Allentown Pennsylvania 18103 United States Details
Local Institution - 0014 Philadelphia Pennsylvania 19104 United States Details
Local Institution - 0020 Philadelphia Pennsylvania 19107 United States Details
Local Institution - 0045 Charleston South Carolina 29425 United States Details
Local Institution - 0034 Nashville Tennessee 37203 United States Details
Local Institution - 0038 Nashville Tennessee 37232 United States Details
Local Institution - 0016 Salt Lake City Utah 84112 United States Details
Local Institution - 0042 Charlottesville Virginia 22908 United States Details
Local Institution - 0028 Clayton Victoria 0 Australia Details
Local Institution - 0050 Bruxelles 1200 Belgium Details
Local Institution - 0051 Edegem 2650 Belgium Details
Local Institution - 0049 Leuven 3000 Belgium Details
Local Institution - 0013 Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0012 Ottawa Ontario K1H 8L6 Canada Details
Local Institution - 0001 Toronto Ontario M5G 1X6 Canada Details
Local Institution - 0022 Dresden 01307 Germany Details
Local Institution - 0007 Heidelberg 69120 Germany Details
Local Institution - 0031 Barcelona 08003 Spain Details
Local Institution - 0032 Madrid 28046 Spain Details
Local Institution - 0030 Majadahonda - Madrid 28222 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field